Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors.

Ahmad S, Hughes MA, Yeh LA, Scott JE.

J Biomol Screen. 2012 Aug;17(7):957-65. doi: 10.1177/1087057112444927. Epub 2012 Apr 24.

PMID:
22535688
[PubMed - indexed for MEDLINE]
2.

Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.

Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh LA, Mani S, Redinbo MR.

Science. 2010 Nov 5;330(6005):831-5. doi: 10.1126/science.1191175.

PMID:
21051639
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A High Throughput Assay for Discovery of Bacterial β-Glucuronidase Inhibitors.

Ahmad S, Hughes MA, Lane KT, Redinbo MR, Yeh LA, Scott JE.

Curr Chem Genomics. 2011;5:13-20. doi: 10.2174/1875397301105010013. Epub 2011 Apr 8.

PMID:
21643506
[PubMed]
Free PMC Article
4.

Cancer. Targeting bacteria to improve cancer therapy.

Patel AG, Kaufmann SH.

Science. 2010 Nov 5;330(6005):766-7. doi: 10.1126/science.1198310. No abstract available.

PMID:
21051622
[PubMed - indexed for MEDLINE]
5.

Old Drug New Use-Amoxapine and Its Metabolites as Potent Bacterial β-Glucuronidase Inhibitors for Alleviating Cancer Drug Toxicity.

Kong R, Liu T, Zhu X, Ahmad S, Williams AL, Phan AT, Zhao H, Scott JE, Yeh LA, Wong ST.

Clin Cancer Res. 2014 Jul 1;20(13):3521-30. doi: 10.1158/1078-0432.CCR-14-0395. Epub 2014 Apr 29.

PMID:
24780296
[PubMed - in process]
6.

Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity.

Roberts AB, Wallace BD, Venkatesh MK, Mani S, Redinbo MR.

Mol Pharmacol. 2013 Aug;84(2):208-17. doi: 10.1124/mol.113.085852. Epub 2013 May 20.

PMID:
23690068
[PubMed - indexed for MEDLINE]
7.

Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats.

Takasuna K, Hagiwara T, Hirohashi M, Kato M, Nomura M, Nagai E, Yokoi T, Kamataki T.

Cancer Chemother Pharmacol. 1998;42(4):280-6.

PMID:
9744772
[PubMed - indexed for MEDLINE]
8.

Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen.

Kurita A, Kado S, Matsumoto T, Asakawa N, Kaneda N, Kato I, Uchida K, Onoue M, Yokokura T.

Cancer Chemother Pharmacol. 2011 Jan;67(1):201-13. doi: 10.1007/s00280-010-1310-4. Epub 2010 Mar 31.

PMID:
20354702
[PubMed - indexed for MEDLINE]
9.

Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.

Bartonícek V.

Med Pharmacol Exp Int J Exp Med. 1967;16(2):142-6. No abstract available.

PMID:
5298397
[PubMed - indexed for MEDLINE]
10.

Experimental observations on the effects of adrenaline after treatment with antidepressant monoamine oxidase inhibitor (MAOI) drugs.

Trinker FR, Fearn H, McCulloch MW, Rand MJ.

Aust Dent J. 1967 Aug;12(4):297-303. No abstract available.

PMID:
5233628
[PubMed - indexed for MEDLINE]
11.

Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.

Stanton HC, Schwartz A.

Proc West Pharmacol Soc. 1966;9:6-8. No abstract available.

PMID:
4381147
[PubMed - indexed for MEDLINE]
12.

Barking up the wrong genome--we are not alone.

Li-Wan-Po A, Farndon P.

J Clin Pharm Ther. 2011 Apr;36(2):125-7. doi: 10.1111/j.1365-2710.2010.01240.x. Epub 2011 Jan 16.

PMID:
21366639
[PubMed - indexed for MEDLINE]
13.

Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats.

Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Keefe DM.

Cancer Biol Ther. 2008 Dec;7(12):1919-25. Epub 2008 Dec 7.

PMID:
18927500
[PubMed - indexed for MEDLINE]
Free Article
14.

Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats.

Takasuna K, Kasai Y, Kitano Y, Mori K, Kobayashi R, Hagiwara T, Kakihata K, Hirohashi M, Nomura M, Nagai E, et al.

Jpn J Cancer Res. 1995 Oct;86(10):978-84.

PMID:
7493918
[PubMed - indexed for MEDLINE]
15.

Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.

Hendley ED, Snyder SH.

Nature. 1968 Dec 28;220(5174):1330-1. No abstract available.

PMID:
5701350
[PubMed - indexed for MEDLINE]
16.

Effect of monoamine oxidase inhibitors on formation of morphine glucuronide.

Yeh SY, Mitchell CL.

Biochem Pharmacol. 1972 Feb 15;21(4):571-8. No abstract available.

PMID:
5014513
[PubMed - indexed for MEDLINE]
17.

Monoamine oxidase inhibitors, combined with thymoleptics: Are they really unusable for human beings?

Bartonícek VJ.

Pharmacology. 1970;4(2):80-90. No abstract available.

PMID:
5528371
[PubMed - indexed for MEDLINE]
18.

Pharmacology of irinotecan.

Kuhn JG.

Oncology (Williston Park). 1998 Aug;12(8 Suppl 6):39-42. Review.

PMID:
9726089
[PubMed - indexed for MEDLINE]
19.

Inhibition of beta-glucuronidase by natural glucuronides of kampo medicines using glucuronide of SN-38 (7-ethyl-10-hydroxycamptothecin) as a substrate.

Narita M, Nagai E, Hagiwara H, Aburada M, Yokoi T, Kamataki T.

Xenobiotica. 1993 Jan;23(1):5-10.

PMID:
8484262
[PubMed - indexed for MEDLINE]
20.

Special application of fluorescence histochemistry: studies on eight monoamine oxidase inhibitors in brain neurons.

Bartonícek VJ.

Pharmacology. 1970;4(1):16-24. No abstract available.

PMID:
4393462
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk